Laurie Stelzer's Net Worth
$4.93 Million
Who is Laurie Stelzer?
Laurie Stelzer has an estimated net worth of $4.93 Million. This is based on reported shares across multiple companies, which include ARENA PHARMACEUTICALS INC, PMV Pharmaceuticals, Inc., HALOZYME THERAPEUTICS, INC., Surface Oncology, Inc., Mirati Therapeutics, Inc., and Spyre Therapeutics, Inc..
SEC CIK
Laurie Stelzer's CIK is 0001644348
Past Insider Trading and Trends
2020 was Laurie Stelzer's most active year for acquiring shares with 9 total transactions. Laurie Stelzer's most active month to acquire stocks was the month of January. 2019 was Laurie Stelzer's most active year for disposing of shares, totalling 8 transactions. Laurie Stelzer's most active month to dispose stocks was the month of January. 2023 saw Laurie Stelzer paying a total of $824,989.00 for 166,117 shares, this is the most they've acquired in one year. In 2021 Laurie Stelzer cashed out on 33,289 shares for a total of $331,491.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ARENA PHARMACEUTICALS INC No price found
EVP & Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -37.21K |
—
|
—
|
0
|
Mar 11
| |||
Form 4
| +144.00% | 21.46K |
—
|
—
| 36.37K |
Jan 3
| |||
Form 4
| +123.78% | 8.24K |
$76.10 | -$331,491.60 | 14.9K |
Mar 16
| |||
Form 4
|
∞
| 6.66K |
—
|
—
| 6.66K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.71
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HALOZYME THERAPEUTICS, INC. (HALO) Snapshot price: $35.45
SVP, Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +6.30% | 6.88K |
$21.83 | -$98,409.64 | 116.17K |
Feb 22
| |||
Form 4
| +4.90% | 5.11K |
$21.10 | -$56,970.00 | 109.28K |
Feb 14
| |||
Form 4
| +7.61% | 7.37K |
$20.00 | -$77,880.00 | 104.17K |
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| +18.11% | 14.84K |
$19.21 | -$158,962.75 | 96.81K |
Feb 3
| |||
Form 4
| +4.42% | 3.47K |
$15.73 | -$53,607.84 | 81.96K |
Jun 15
| |||
Form 4
| +10.49% | 7.45K |
$16.81 | -$66,214.59 | 78.5K |
Feb 22
| |||
Form 4
| +7.75% | 5.11K |
$16.54 | -$44,658.00 | 71.04K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
| +28.95% | 14.8K |
$16.12 | -$134,070.04 | 65.93K |
Feb 3
| |||
Form 4
| +7.62% | 3.62K |
$19.02 | -$61,891.08 | 51.13K |
Jun 15
| |||
Form 4
| +18.61% | 7.45K |
$19.28 | -$75,943.92 | 47.51K |
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +58.94% | 14.86K |
$18.37 | -$151,828.05 | 40.06K |
Feb 3
| |||
Form 4
| +20.53% | 4.29K |
$13.05 | -$33,708.15 | 25.2K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| +204.15% | 14.04K |
$12.26 | -$111,382.10 | 20.91K |
Feb 3
| |||
Form 4
| +68.75% | 6.88K |
—
|
—
| 16.88K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4/A
|
∞
| 10K |
$17.24 | $172,384.00 | 10K |
Aug 20
| |||
Form 4
|
∞
| 10K |
$17.24 | $172,384.00 | 10K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Surface Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mirati Therapeutics, Inc. (MRTX) No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +27.87% | 22.3K |
$37.00 | $824,989.00 | 102.31K |
Aug 9
| |||
Form 4
| -5.49% | -4.65K |
$37.06 | -$172,217.82 | 80.02K |
Jun 2
| |||
Form 4
| +46.48% | 26.86K |
—
|
—
| 84.66K |
Jan 20
| |||
Form 4
|
∞
| 57.8K |
—
|
—
| 57.8K |
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||